Last reviewed · How we verify
Placebo for Hydrochlorothiazide — Competitive Intelligence Brief
phase 3
Cardiovascular
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo for Hydrochlorothiazide (Placebo for Hydrochlorothiazide) — IlDong Pharmaceutical Co Ltd. A placebo contains no active pharmaceutical ingredient and produces no pharmacological effect.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo for Hydrochlorothiazide TARGET | Placebo for Hydrochlorothiazide | IlDong Pharmaceutical Co Ltd | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo for Hydrochlorothiazide CI watch — RSS
- Placebo for Hydrochlorothiazide CI watch — Atom
- Placebo for Hydrochlorothiazide CI watch — JSON
- Placebo for Hydrochlorothiazide alone — RSS
Cite this brief
Drug Landscape (2026). Placebo for Hydrochlorothiazide — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-for-hydrochlorothiazide. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab